Gilead Sciences and Genesis Pharma have entered into a collaboration to discover, develop, and commercialize small molecule drugs. The companies will leverage Genesis’s expertise in medicinal chemistry and Gilead’s experience in drug development and commercialization. The collaboration will focus on undisclosed targets and disease areas.
